Greater than 90.0% as determined by SDS-PAGE.
Soluble FGFR-2a (IIIc) Fc Chimera Human Recombinant fused with Xa cleavage site with the Fc part of human IgG1 produced in baculovirus is a heterodimeric, glycosylated, Polypeptide chain containing 602 amino acids and having a molecular mass of 170 kDa.
The FGFR2 is purified by proprietary chromatographic techniques.
RPSFSLVEDTTLEPEEPPTKYQISQPEVYVAAPGESLEVRCLLKDAAVISWT KDGVHLGPNNRTVLIGEYLQIKGATPRDSGLYACTASRTVDSETWYFMVNVT DAISSGDDEDDTDGAEDFVSENSNNKRAPYWTNTEKMEKRLHAVPAANTVKF RCPAGGNPMPTMRWLKNGKEFKQEHRIGGYKVRNQHWSLIMESVVPSDKGNY TCVVENEYGSINHTYHLDVVERSPHRPILQAGLPANASTVVGGDVEFVCKVY SDAQPHIQWIKHVEKNGSKYGPDGLPYLKVLKAAGVNTTDKEIEVLYIRNVT FEDAGEYTCLAGNSIGISFHSAWLTVLPAPGREKEITASPDYLEDPRRASIE GRGDPEEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTC VVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDW LNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSRDELTKNQVSL TCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRW QQGNVFSCSVMHEALHNHYTQKSLSLSPGK
FGFR2 exists in multiple isoforms due to alternative splicing of its mRNA. The two main isoforms are FGFR2 alpha (IIIb) and FGFR2 beta (IIIc), which differ in their ligand-binding specificities and tissue distribution . The alpha isoform contains all three immunoglobulin (Ig) domains, while the beta isoform contains only IgII and IgIII domains .
The FGFR2 Fc Chimera is a recombinant fusion protein that combines the extracellular domain of FGFR2 with the Fc region of human IgG1 . This fusion enhances the stability and solubility of the receptor, making it suitable for various research applications. The Fc region also allows for easy purification using protein A or G affinity chromatography .
The FGFR2 Fc Chimera is typically produced in insect cells using a baculovirus expression system . The recombinant protein is then purified using proprietary chromatographic techniques to achieve high purity levels (>90%) as determined by SDS-PAGE . The lyophilized protein is stable at room temperature for several weeks but should be stored at -18°C for long-term storage .
The biological activity of the FGFR2 Fc Chimera is determined by its ability to inhibit FGF-dependent proliferation of various cell types . For example, it has been shown to inhibit the proliferation of NR6R-3T3 mouse fibroblast cells and human umbilical vein endothelial (HUVE) cells . The effective dose (ED50) for these effects is typically in the range of 1-30 ng/mL .